17:13 EDT Benitec Biopharma (BNTC) files to sell 900K shares of common stock for holders
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNTC:
- Positive Buy Recommendation for Benitec Biopharma Driven by Promising Clinical Progress and Strong Financial Position
- Benitec Biopharma reports Q3 EPS (24c) vs. (23c) last year
- Benitec Biopharma price target raised to $20 from $18 at Citizens JMP
- Promising Clinical Results and Financial Stability Drive Buy Rating for Benitec Biopharma
- new option listings on April 9th
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue